Ligand, Spectrum sign Captisol-enabled Melphalan licensing, supply deal
The contract will focus on the development and commercialization of Ligand’s Captisol-enabled, propylene glycol-free (PG-free) melphalan. According to the agreement, Ligand will earn license fee and is eligible
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.